is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis
An in-depth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments
Intelligence on Astellas Pharma Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Astellas Pharma (Astellas or 'the company') is engaged in the manufacture, marketing, import and export of pharmaceuticals and related products. The company operates in Japan, Asia, the Americas, Europe, Middle East, and Africa (EMEA) and Oceania. It is headquartered in Tokyo, Japan and employed 17,649 people as of March 31, 2014. The company recorded revenues of JPY1,139,909 million (approximately $11,399.1 million) during the financial year ended March 2014 (FY2014), an increase of 16.1% over FY2013. The operating profit of the company was JPY116,806 million (approximately $1,168.1 million) in FY2014, a decrease of 3.9% compared with FY2013. The net profit of the company was JPY90,874 million (approximately $908.7 million) in FY2014, a decrease of 1.7% compared with FY2013.
Reasons to Purchase:
Gain understanding of Astellas Pharma Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Astellas Pharma Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Astellas Pharma Inc.’s business structure, strategy and prospects